| Net Cash Provided by (Used in) Operating Activities |
$627,778 |
USD |
-19% |
Q4 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$29,864 |
USD |
|
Q4 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q4 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
65,779,045 |
shares |
24% |
Q4 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$657,642 |
USD |
-25% |
Q4 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$5,898,000 |
USD |
717% |
Q4 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$13,024,656 |
USD |
3.7% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$13,026,211 |
USD |
3.7% |
Q3 2025 |
FY 2025 |
| Depreciation |
$3,899 |
USD |
137% |
Q4 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,278,274 |
USD |
35% |
Q4 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$217,254 |
USD |
45% |
Q4 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$9,628,736 |
USD |
5.8% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q4 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
$87,475,862 |
USD |
4.6% |
Q4 2025 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,555 |
USD |
88% |
Q3 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$51,563 |
USD |
122% |
Q4 2024 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q4 2025 |
Q1 2025 |